
|Videos|December 13, 2022
Importance of Clinical Trial Data, Disease Control, and QoL in Atopic Dermatitis Management
Author(s)Raj Chovatiya, MD, PhD, MSCI, Neal Bhatia, MD
Raj Chovatiya, M.D., Ph.D. and Neal Bhatia, MD comment on the importance of assessing a treatment’s available clinical trial data, ability to control disease severity, and QoL impacts when assessing atopic dermatitis treatment options.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
AbbVie Completes $10.9 Billion Apogee Acquisition, Adds Zumilokibart to AD Pipeline
2
Journal Digest: September 2, 2026
3
Uncovering the Autoimmune Links & Systemic Impact of Chronic Spontaneous Urticaria
4
Dermatology Times Launches Derm Nexus Congress for NPs and PAs
5











